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Persistent autonomous ovarian dysfunction in McCune-
Albright syndrome (MAS) patients is associated with the de-
velopment of multiple dominant follicles, premature lutein-
ization, cyst formation, and anovulatory infertility. Due to the
mosaic distribution of the mutation, ovaries may be unequally
affected. In the current patient, the least affected ovary be-
came quiescent upon GnRH agonist-induced gonadotropin
suppression. Normoovulatory cycles were restored after sub-
sequent removal of the affected right ovary, and a pregnancy
was established within 3 months. A healthy unaffected girl
was born at term after an uneventful pregnancy. The placen-
tal tissue was normal, and the mutation was not detected in
the placenta, umbilical cord structures, or umbilical cord
blood. GnRH analog administration may help to identify those
MAS patients who might benefit from unilateral ovariectomy.
Because a healthy baby was born, evidence is provided sug-
gesting that MAS is not passed on to the children from the
parents. (J Clin Endocrinol Metab 89: 1076–1078, 2004)
POLYOSTOTIC FIBROUS DYSPLASIA, cafe´ au lait spots,sexual precocity, and hyperfunction of multiple endo-
crine glands constitute the key features of McCune-Albright
syndrome (MAS). The syndrome is due to a somatic muta-
tion in the GNAS1 gene (1, 2). Missense point mutations at
codon 201 substituting Arg with either Cys or His give rise
to abnormal Gs proteins that reduce the intrinsic guanosine
triphosphatase activity, thereby constitutively activating the
Gs protein (3–5). The extent and nature of the abnormality are
highly variable, depending on the specific tissues involved
due to the mosaic distribution of the GNAS1 mutation (3).
The most commonly encountered endocrine dysfunction
in MAS is gonadal hyperfunction. Precocious puberty rep-
resents the usual initial manifestation of MAS in girls. Ovar-
ian cysts may be found upon pelvic ultrasound (6, 7). Other
endocrine abnormalities include hyperfunction of the thy-
roid and adrenal cortex as well as excessive GH secretion.
The majority of patients have abnormally elevated sex ste-
roids with low or undetectable gonadotropin levels. Al-
though pregnancies have been described later in life (8–10),
polymenorrhea and amenorrhea due to continued gonado-
tropin-independent estrogen production have also been
reported (6, 11). However, clinical information regarding
ovarian dysfunction in McCune-Albright patients during ad-
olescent and adult life is scant.
In a recent paper, we provided evidence for persistent
autonomous unilateral ovarian dysfunction in an adult
woman suffering from MAS. Because MAS patients show a
typical unilateral involvement of symmetrical tissues, the
mutation is usually only present or more abundant in either
one of the ovaries. Increased FSH and LH signaling gave rise
to the development of multiple dominant follicles, premature
luteinization, anovulation, and cyst formation in the affected
ovary. As a result of the sex steroid-rich endocrine environ-
ment, gonadal function in the unaffected contralateral ovary
is usually also disturbed. Endometrial function may be also
disrupted presumably due to elevated progesterone levels
throughout the cycle, implying that embryo implantation
might be severely compromised, representing an additional
factor in infertility (11). Hence, removal of the affected ovary
might restore a normal endocrine environment, and subse-
quently normal ovarian function might be restored in the
remaining gonad, rendering these patients fertile.
Case Report
A 22-yr-old patient previously diagnosed as having MAS attended
our outpatient clinic for fertility counseling. She exhibited the classical
clinical triad of polyostotic fibrous dysplasia, along with large cafe´ au
lait spots in the lumbosacral region and a history of precocious puberty
and irregular menstrual bleeding. DNA analysis revealed a mutation
(201 Arg to His) present in the right ovary only, as well as in the
endometrium (11). As previously described, increased FSH and LH
signaling gave rise to the development of multiple dominant follicles,
premature luteinization, anovulation, and cyst formation in the affected
ovary. The function in the contralateral unaffected ovary was also dis-
turbed due to continuously elevated sex steroid levels (11).
In an attempt to suppress the function of the unaffected ovary, a
GnRH agonist (Zoladex, AstraZeneca, Zoetermeer, The Netherlands)
known to induce suppression of pituitary gonadotropin release was
administered for 1 month. This investigation was performed to test the
hypothesis that the unaffected ovary would be rendered quiescent due
to the lack of tropic support, whereas the affected ovary would continue
to function autonomously. Weekly transvaginal ultrasound showed a
progressive disappearance of ovarian cysts in the left ovary during
GnRH agonist administration, indicating that this ovary is normally
responsive to FSH and LH. In contrast, the affected ovary on the right
side did not respond and continued to function abnormally.
These results as well as the experimental nature of the proposed
unilateral ovariectomy were discussed extensively in our team and with
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the patient. Moreover, the local Institutional Review Board was in-
formed before the investigations had been carried out. Because only one
fully informed patient was involved, a research protocol approval was
not required. Subsequently, unilateral ovariectomy was performed
through laparoscopy under general anesthesia. Upon laparoscopy, an
enlarged (5 5 8-cm) cystic ovary was easily removed. Care was taken
to leave the fallopian tube on the right side intact. The left ovary had a
normal appearance, as had the remaining internal genital organs. Sec-
tions of the left ovary were prepared as previously described (11). Upon
microscopic examination, primordial, primary, and secondary follicles
along with Graaffian structures were found. Although all stages of
follicular development were present, larger follicles were luteinized
without exception. The mutation was readily detectable throughout the
removed ovary. Again, both canonical and mutant sequences present
were indicative of the mosaic nature of the disease.
The patient recovered rapidly after the operation, and a regular men-
strual cycle (28–30 d) was immediately restored. During the third cycle,
she spontaneously conceived after a previous 4-yr period of infertility.
After an uneventful pregnancy, at 40 wk a healthy daughter weighing
3800 g was delivered vaginally. The placenta appeared normal (650 g),
and the baby displayed no external stigmata of MAS. The placental
tissue was normal on microscopic examination. No evidence of the
GNAS1 mutation was found in the placenta, umbilical cord, or cord
blood (Fig. 1). The daughter is now 11⁄2 yr old, and her development
remains normal.
Discussion
The current findings suggest that it may be useful to apply
an in vivo test using a GnRH agonist to investigate whether
the least or nonaffected ovary in MAS patients is normally
responsive to diminished stimulation by gonadotropins.
Moreover, the current case history provides evidence to sup-
port the concept that in adult MAS patients with persistent
unilateral autonomous ovarian activity, ovarian and endo-
metrial function can be restored through removal of the
affected ovary. Finally, because an unaffected healthy
daughter was born, this report provides further evidence that
MAS is caused by an autosomal dominant lethal gene that is
compatible with viability of the conceptus only when it oc-
curs in the mosaic state. Hence, MAS results from a somatic
mutation and therefore may not be inherited through an
affected parent.
Our patient showed a typical unilateral involvement of
tissue because the mutation was only found in the right
polycystic ovary. This might be due to either a reduced
number or an absence of mutated cells present in the left
ovary not being detected by DNA analysis (11). Neverthe-
less, this difference in expression of the mutation seems to be
compatible with normal monofollicular growth in the left
ovary. However, this potentially normal ovary was still dys-
functional as a result of the abnormal sex steroid-rich endo-
crine environment induced by its affected counterpart. Re-
moval of the right ovary might restore normal function of the
remaining left ovary and should be considered. Testing
whether this is a feasible approach may be done using an in
vivo GnRH agonist test. If the unaffected ovary becomes
quiescent under GnRH analog administration, it may be
justified to remove the affected ovary. The abnormal endo-
crine environment, which may also affect both oocyte and
endometrial function and, consequently, the outcome of in
vitro fertilization, cannot be otherwise corrected. Hence,
ovariectomy may constitute the only treatment option in
symptomatic adult MAS women (11).
It has been postulated that the presence of mutated cells
in the endometrium might also compromise endometrial
receptivity and natural fertility (11). Surprisingly, this seems
not to be the case because the patient conceived readily after
ovariectomy. Because the mutated endometrial cells were
only found in the anterior lining of the uterus, the remaining
endometrium was apparently functionally normal. More-
over, nidation and placentation, as observed by ultrasound
scans during early pregnancy, took place in the posterior
nonaffected endometrial lining.
Happle (3) made the intriguing suggestion that this dis-
order is caused by an autosomal dominant lethal gene that
is compatible with viability of the conceptus only when it
occurs in the mosaic state, having arisen by somatic muta-
tion. MAS has been reported to occur in one set of monozy-
gotic twin girls of whom only one showed major signs of
MAS whereas the other showed only mild radiological signs
of the disease (12). However, the lack of fully convincing
familial cases is consistent with the mosaic mutation hypoth-
esis. In the present case, the daughter displayed no signs of
MAS. Because the mutation analysis was also negative, she
is unlikely to be affected. This provides further evidence for
the Happle hypothesis, hereby excluding any possibility of
transmission from the parents.
In conclusion, the present report shows that normal ovar-
ian and reproductive function in MAS patients can be re-
stored through unilateral ovariectomy, provided the unaf-
fected ovary is successfully suppressed upon GnRH agonist
FIG. 1. Direct DNA sequencing showed the presence of a guanine to
adenine transversion (G/A*) leading to an Arg-His substitution at
position 201 in the right ovary. Both canonical and mutant sequences
were present, the latter with a weaker intensity (green) indicating a
mosaicism of normal and abnormal cells. The mutation was not de-
tectable in the left ovary or in the placental tissue.
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administration. Furthermore, evidence is provided that MAS
might not be passed on to children by their parents.
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